In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...
Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...
In a tearful video posted to Instagram, the 30-year-old from Pheonix, Arizona admitted she took the drug after struggling ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
Discover the unexpected health benefits of diabetes and weight loss medications like Ozempic and Wegovy. Find out how these ...
Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback